TP53 and esophageal adenocarcinoma: A similar approach has been investigated in the United Kingdom using the Cytosponge device, in which the absence of p53 overexpression and cytologic atypia—combined with demographic risk factors—was associated with a 99% NPV for HGD/esophageal adenocarcinoma using p53 (41).